Singapore’s Health Sciences Authority (HSA) has expanded the label of GlaxoSmithKline (GSK)’s Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) to ...

GlaxoSmithKline is to sell a portfolio of anaesthetics to South Africa’s Aspen in a deal worth up to £280 million. The companies, which have worked closely together for several years ...

With the approval, GSK adds a key new option to its market-leading meningitis vaccine portfolio. In a phase 3 study, GSK's vaccine—given in two doses six months apart—showed immunological ...

An improved long-term sales target today revitalised GSK shares after their dismal 2024 ... rental homes with a 3.4 billion operational portfolio, led the mid-cap benchmark after reporting ...

Senior Vice President, Head of R&D China, GlaxoSmithKline ... we now have about 210 staff in Shanghai and about 50 staff in Singapore. Approximately 45% of the staff have been recruited from ...